What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

TATA Box Transcription: Role, Mechanism, and Study Methods

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Introduction to the TATA Box and Transcription Initiation

Transcription is the process by which RNA polymerase synthesizes RNA from a DNA template. In eukaryotes, this process is far more complex than in bacteria, requiring a suite of general transcription factors to assemble at the promoter before RNA polymerase II can begin synthesis. At the heart of this assembly lies a short, conserved DNA sequence known as the TATA box.

The TATA box is a core promoter element that serves as the primary binding site for the TATA-binding protein (TBP), a subunit of the general transcription factor TFIID. Its name derives from its consensus sequence, which is rich in thymine and adenine residues. The TATA box is typically located approximately 25–30 base pairs upstream of the transcription start site (TSS), positioning it precisely where the preinitiation complex (PIC) must form. This positioning is not arbitrary; the binding of TBP to the TATA box induces a sharp bend in the DNA, which serves as a landmark for the recruitment of RNA polymerase II and the remaining general transcription factors. Without this nucleation event, promoter recognition and transcription initiation would be severely impaired.

The fundamental role of the TATA box is therefore to act as a molecular anchor. It provides the sequence-specific signal that allows the transcriptional machinery to identify where transcription should begin and orients the machinery in the correct direction. While not all eukaryotic promoters contain a TATA box, those that do rely on it as a critical determinant of both the efficiency and the precision of Transcription Initiation.

What is the TATA box?

The TATA box is a cis-acting DNA element, meaning it exerts its effect on the same molecule of DNA on which it resides. It is a component of the core promoter, the minimal region of DNA required for RNA polymerase II to initiate transcription accurately. The TATA box is recognized by the TATA-binding protein, which is the DNA-binding subunit of the TFIID complex. This interaction is the first committed step in the assembly of the PIC.

Biochemically, the TATA box is a minor-groove binding site. Unlike many sequence-specific DNA-binding proteins that insert alpha-helices into the major groove, TBP binds to the minor groove and interacts with the bases without making direct contact with the phosphodiester backbone in the conventional manner. This unusual mode of binding allows TBP to recognize the TATA sequence with high specificity while simultaneously inducing a dramatic conformational change in the DNA.

Consensus sequence and location

The canonical TATA box consensus sequence is 5′-TATAWAWR-3′, where W represents adenine or thymine and R represents adenine or guanine. In practice, the most commonly cited consensus is 5′-TATAAA-3′, which is the sequence found in many well-characterized promoters, including the adenovirus major late promoter and the yeast CYC1 promoter. The sequence is AT-rich, which is functionally significant because the minor groove of AT-rich DNA is narrower and more easily deformed than that of GC-rich DNA, facilitating the bending required for TBP binding.

The location of the TATA box is tightly constrained. In most eukaryotic promoters, it is found 25–30 base pairs upstream of the +1 transcription start site. This distance is measured from the first base of the TATA box to the +1 position. The precise spacing is critical; shifting the TATA box by even a few base pairs can alter the position of the transcription start site or reduce promoter strength. In yeast, the TATA box is often found at a slightly greater distance, approximately 40–120 base pairs upstream of the start site, reflecting differences in promoter architecture between species.

The TATA Box as a Core Promoter Element

The core promoter is the minimal DNA region that directs accurate initiation of transcription by RNA polymerase II. It typically spans from approximately −40 to +40 relative to the transcription start site. The TATA box is one of several core promoter elements, each of which contributes to promoter function in a distinct manner. Understanding the TATA box requires placing it within this broader architectural context.

Core promoter architecture

The core promoter is composed of multiple sequence elements that serve as binding sites for general transcription factors. These elements include:

The TATA box (approximately −30 to −25): Bound by TBP.
The initiator (Inr) (approximately −2 to +4): A pyrimidine-rich sequence (consensus YYANWYY, where Y is pyrimidine, N is any base, and W is A or T) that encompasses the transcription start site. The Inr is recognized by TFIID subunits other than TBP, specifically TAF1 and TAF2.
The downstream promoter element (DPE) (approximately +28 to +32): A purine-rich sequence (consensus RGWYV) found in TATA-less promoters, recognized by TAF6 and TAF9.
The TFIIB recognition element (BRE) (approximately −37 to −32 and +1 to +6): Recognized by the general transcription factor TFIIB.

These elements function in a modular fashion. A given promoter may contain some or all of these elements, and the combination determines the promoter's strength and its responsiveness to regulatory signals. The TATA box is the best-characterized of these elements, but it is not universal.

TATA vs. TATA-less promoters

A major distinction in eukaryotic promoter biology is between TATA-containing and TATA-less promoters. Estimates suggest that only about 10–20% of human promoters contain a canonical TATA box. The majority of promoters are TATA-less and instead rely on the Inr and DPE elements for basal transcription.

TATA-containing promoters are typically associated with highly regulated, tissue-specific genes. For example, the promoter of the HBB gene (encoding beta-globin) contains a TATA box, and mutations in this element cause beta-thalassemia. In contrast, TATA-less promoters are more common among housekeeping genes, which are constitutively expressed at relatively constant levels. The GAPDH gene, encoding glyceraldehyde-3-phosphate dehydrogenase, is a classic example of a TATA-less promoter that relies on a GC-rich region and Inr elements.

The distinction matters mechanistically. In TATA-containing promoters, TBP binding to the TATA box is the primary nucleation event for PIC assembly. In TATA-less promoters, PIC assembly is instead nucleated by TFIID binding to the Inr and DPE elements, with TBP being recruited to the promoter indirectly through its association with TAFs. This difference has practical consequences: TATA-less promoters are generally less sensitive to TBP concentration and may be regulated by different signaling pathways.

Feature	TATA-containing promoters	TATA-less promoters
Frequency in human genome	~10–20%	~80–90%
Core elements	TATA box, Inr, BRE	Inr, DPE, GC-rich motifs
Typical gene types	Tissue-specific, inducible	Housekeeping, constitutively expressed
PIC nucleation	TBP–TATA interaction	TFIID–Inr/DPE interaction
Example genes	HBB, CYP1A1, ADH1	GAPDH, ACTB, HPRT1
Sensitivity to TBP levels	High	Lower

Molecular Mechanism: TATA-Binding Protein (TBP) and TFIID

The molecular mechanism by which the TATA box directs transcription initiation is a paradigm of protein–DNA recognition and nucleoprotein complex assembly. The process begins with TBP and culminates in the formation of a fully assembled PIC containing RNA polymerase II and all six general transcription factors (TFIIA, TFIIB, TFIID, TFIIE, TFIIF, and TFIIH).

TBP-DNA interaction

TBP is a 38 kDa protein in humans (180 kDa in yeast, where it contains an N-terminal extension) that binds the TATA box with high affinity. The dissociation constant (Kd) for the TBP–TATA interaction is typically in the nanomolar range (approximately 1–10 nM), reflecting a strong and specific interaction.

The structure of TBP is remarkable. It is shaped like a saddle, with two conserved domains of approximately 90 amino acids each that are structurally similar. The concave surface of the saddle contacts the DNA, while the convex surface is available for interactions with other proteins. TBP binds to the minor groove of the TATA box, which is unusual because most sequence-specific DNA-binding proteins interact with the major groove.

Upon binding, TBP induces a dramatic bend in the DNA of approximately 80–90 degrees. This bend is achieved through the intercalation of phenylalanine residues from TBP between the base pairs of the TATA sequence, causing a local unwinding and kinking of the helix. The bend is important for two reasons. First, it creates a distorted DNA structure that is recognized by TFIIB, which binds to the TBP–DNA complex. Second, the bend helps to position the transcription start site relative to the active site of RNA polymerase II.

The specificity of TBP for the TATA sequence arises from direct hydrogen bonds between conserved asparagine and glutamine residues in TBP and the edges of the adenine and thymine bases exposed in the minor groove. The AT-rich nature of the TATA box is critical because the minor groove of AT-rich DNA is narrower and more flexible, allowing the required conformational changes to occur with lower energetic cost.

Assembly of the preinitiation complex

The assembly of the PIC proceeds through a defined sequence of steps, each of which is driven by specific protein–protein and protein–DNA interactions:

TBP binding: TBP, as part of the TFIID complex, binds to the TATA box. TFIID is a large multi-subunit complex (approximately 1.2 MDa) containing TBP and 13–14 TBP-associated factors (TAFs). The TAFs contribute to promoter recognition by binding to the Inr and DPE elements and also serve as targets for transcriptional activators.

TFIIA and TFIIB recruitment: TFIIA binds to the TBP–DNA complex, stabilizing the interaction and protecting it from inhibitors. TFIIB then binds to the TBP–DNA complex, recognizing both the TBP saddle and the bent DNA. TFIIB makes sequence-specific contacts with the BRE element and helps to recruit RNA polymerase II.

RNA polymerase II and TFIIF binding: RNA polymerase II, in complex with TFIIF, is recruited to the promoter through interactions with TFIIB. TFIIF binds to the polymerase and helps to stabilize its association with the promoter.

TFIIE and TFIIH binding: TFIIE binds to the polymerase and recruits TFIIH. TFIIH is a multi-subunit complex with helicase activity (subunits XPB and XPD) and kinase activity (subunit CDK7). The helicase activity of XPB is required for promoter melting, the process by which the DNA strands are separated to expose the template strand.

Promoter melting and initiation: TFIIH uses ATP hydrolysis to drive the unwinding of approximately 11–15 base pairs of DNA around the transcription start site, forming the open complex. RNA polymerase II then begins synthesizing RNA, and after the synthesis of approximately 10–15 nucleotides, the polymerase escapes the promoter and enters the elongation phase.

This ordered assembly is the canonical pathway for PIC formation. It is important to note that the TATA box is not merely a passive binding site; the bend induced by TBP is structurally required for the correct positioning of TFIIB and RNA polymerase II. Mutations that alter the bendability of the TATA sequence reduce transcription even if they do not abolish TBP binding, highlighting the importance of the induced fit.

Regulation of TATA Box-Dependent Transcription

The TATA box provides a baseline level of transcription, but the actual rate of transcription is determined by the interplay between the core promoter and regulatory elements such as enhancers and silencers. These elements can act over long distances and are brought into proximity with the core promoter through DNA looping.

Enhancers and silencers

Enhancers are DNA elements that bind sequence-specific Transcription Factor proteins and activate transcription from a linked promoter. They can be located thousands of base pairs upstream or downstream of the transcription start site and function in an orientation-independent manner. Silencers are analogous elements that repress transcription.

The TATA box is a major target of enhancer action. Activator proteins bound at enhancers recruit coactivator complexes, such as the Mediator complex and histone acetyltransferases (HATs), which in turn stimulate PIC assembly at the core promoter. Many activators directly contact TFIID, stabilizing its binding to the TATA box. For example, the viral activator VP16 from herpes simplex virus binds to TAFII31 (TAF9) and TAFII40 (TAF12), enhancing the recruitment of TFIID to TATA-containing promoters.

The presence of a TATA box makes a promoter highly responsive to activators. This is because the TATA box provides a well-defined, high-affinity binding site for TBP, and the PIC assembly pathway is rate-limiting. Activators can overcome this limitation by recruiting limiting components of the PIC. In contrast, TATA-less promoters are often less responsive to activators because their PIC assembly is nucleated by different, less well-defined interactions.

Chromatin remodeling and TATA accessibility

In the context of chromatin, the TATA box is not always accessible. In eukaryotic cells, DNA is wrapped around histone octamers to form nucleosomes, which can occlude the TATA box and prevent TBP binding. The accessibility of the TATA box is therefore a key regulatory point.

Two classes of enzymes regulate chromatin accessibility:

ATP-dependent chromatin remodelers: Complexes such as SWI/SNF and RSC in yeast (BAF and PBAF in humans) use the energy of ATP hydrolysis to slide, eject, or restructure nucleosomes. These complexes can expose the TATA box, allowing TBP to bind.
Histone-modifying enzymes: Histone acetyltransferases (HATs) such as Gcn5 and p300/CBP acetylate lysine residues on histone tails, neutralizing their positive charge and weakening histone–DNA interactions. This promotes a more open chromatin structure. Histone deacetylases (HDACs) reverse this modification, promoting chromatin compaction and reducing TATA accessibility.

The interplay between these enzymes and the TATA box is particularly important during gene activation. For example, in yeast, the PHO5 promoter contains a TATA box that is initially occluded by positioned nucleosomes. Upon phosphate starvation, the Pho4 activator recruits the SWI/SNF complex, which remodels the nucleosomes and exposes the TATA box, allowing transcription to proceed.

TATA Box Variations and Their Functional Consequences

The TATA box is a functional element whose sequence directly determines its activity. Variations in the TATA box sequence can have profound effects on transcription levels, and in humans, such variations are associated with a range of genetic diseases.

Single nucleotide polymorphisms

Single nucleotide polymorphisms (SNPs) in the TATA box can alter its affinity for TBP and thereby change promoter strength. The effect of a given SNP depends on its position and the specific base change. For example, the canonical sequence TATAAA is a high-affinity binding site. Changing the first T to a C (CATAAA) reduces TBP binding affinity by approximately 10-fold, leading to a corresponding reduction in transcription.

The relationship between TATA box sequence and promoter strength has been systematically studied. In general, the most important positions are the first, second, and fourth bases. The consensus TATA is the optimal sequence; deviations from this consensus reduce binding affinity. However, some variations are tolerated better than others. For instance, TATATA and TATAAA have similar affinities, while TATAGA binds significantly less well.

Disease-associated TATA mutations

Mutations in TATA boxes are the cause of several human genetic diseases. The most well-characterized examples are in the beta-globin gene cluster:

Beta-thalassemia: Mutations in the TATA box of the HBB gene reduce transcription by 10–20% of normal levels, leading to reduced beta-globin synthesis and the clinical phenotype of beta-thalassemia. The most common mutation is a T-to-C transition at position −28 relative to the transcription start site (TATA → CATA). Another mutation at position −30 (TATA → TACA) has a similar effect.

Hereditary persistence of fetal hemoglobin (HPFH): In contrast, some TATA box mutations in the gamma-globin genes increase transcription, leading to continued expression of fetal hemoglobin in adults. This condition is generally benign and can even ameliorate the symptoms of sickle cell disease.

Other examples include mutations in the TATA box of the UGT1A1 gene, which cause Gilbert's syndrome, a mild form of unconjugated hyperbilirubinemia. The most common variant is a TA insertion in the TATA box, resulting in the sequence A(TA)7TAA instead of the wild-type A(TA)6TAA. This reduces UGT1A1 expression to approximately 30% of normal, impairing bilirubin conjugation.

The study of these natural mutations has provided valuable insights into the quantitative relationship between TATA box sequence, TBP binding, and transcription output.

Experimental Methods to Study the TATA Box

Investigating TATA box function requires a combination of biochemical, genetic, and structural approaches. Each method provides complementary information about the role of the TATA box in transcription.

Reporter gene assays

Reporter gene assays are the most direct method for measuring the transcriptional activity of a TATA box. In a typical assay, a promoter fragment containing the TATA box is cloned upstream of a reporter gene encoding an easily measurable enzyme, such as firefly luciferase, beta-galactosidase, or green fluorescent protein (GFP). The construct is transfected into cultured cells, and reporter activity is measured after 24–48 hours.

To study the TATA box specifically, a minimal promoter containing only the TATA box and an Inr element is used. Mutations are introduced into the TATA box by site-directed mutagenesis, and the effect on reporter activity is quantified. This approach allows the determination of the relative strength of different TATA box variants. For example, a series of TATA box mutants can be tested to establish the consensus sequence that gives maximal activity.

A common variation is the use of a dual-luciferase assay, in which a firefly luciferase reporter is co-transfected with a Renilla luciferase control. The Renilla luciferase activity serves as an internal control for transfection efficiency, allowing normalization of the firefly luciferase signal.

Electrophoretic mobility shift assay (EMSA)

The electrophoretic mobility shift assay, also known as a gel shift assay, is used to measure the binding of TBP to the TATA box in vitro. In this assay, a short double-stranded DNA oligonucleotide (typically 20–40 base pairs) containing the TATA box is labeled with a radioactive or fluorescent tag. The labeled DNA is incubated with recombinant TBP or nuclear extract, and the mixture is resolved on a non-denaturing polyacrylamide gel.

Protein–DNA complexes migrate more slowly than free DNA, producing a shifted band on the gel. The intensity of the shifted band reflects the amount of TBP bound to the DNA. By varying the concentration of TBP, the dissociation constant (Kd) for the interaction can be determined. Competition experiments, in which unlabeled DNA competitors are added, can be used to assess the relative affinity of TBP for different TATA box sequences.

A typical EMSA reaction contains 10 mM Tris-HCl (pH 7.5), 50 mM KCl, 5 mM MgCl2, 1 mM DTT, 5% glycerol, and 0.1 mg/mL bovine serum albumin. The binding reaction is incubated at 30°C for 20–30 minutes before loading onto a 4–6% polyacrylamide gel.

Chromatin immunoprecipitation (ChIP)

Chromatin immunoprecipitation is used to study TBP binding to the TATA box in living cells. In a ChIP experiment, cells are treated with formaldehyde to cross-link proteins to DNA. The cells are then lysed, and the chromatin is sheared by sonication into fragments of approximately 200–600 base pairs. An antibody specific to TBP is used to immunoprecipitate TBP–DNA complexes. After reversing the cross-links, the DNA is purified and analyzed by quantitative PCR (qPCR) or next-generation sequencing (ChIP-seq).

ChIP can be used to measure the occupancy of TBP at a specific promoter under different conditions. For example, one can compare TBP occupancy at a TATA-containing promoter in the presence and absence of a transcriptional activator. The results provide information about the dynamics of PIC assembly in vivo.

A typical ChIP protocol involves cross-linking with 1% formaldehyde for 10 minutes at room temperature, quenching with 125 mM glycine, and sonicating to achieve DNA fragments of 200–600 base pairs. The immunoprecipitation is performed with 1–5 μg of antibody per 25 μg of chromatin, and the purified DNA is analyzed by qPCR using primers flanking the TATA box.

X-ray crystallography and cryo-EM

Structural studies have provided atomic-level detail on how TBP recognizes the TATA box. The first crystal structure of a TBP–TATA box complex was solved in 1993 by the laboratories of Paul Sigler and Stephen Burley. The structure revealed the saddle-shaped TBP molecule bound to the minor groove of the DNA, with the DNA bent by approximately 80 degrees.

More recently, cryo-electron microscopy (cryo-EM) has been used to determine the structures of complete preinitiation complexes. In 2016, the Nogales laboratory published a cryo-EM structure of the human PIC at 3.4 Å resolution, revealing the precise arrangement of TBP, TFIIA, TFIIB, TFIIF, and RNA polymerase II at the promoter. These structures have confirmed the central role of the TATA box in positioning the transcriptional machinery and have revealed the conformational changes that occur during promoter melting.

For structural studies, TBP is typically expressed in E. coli and purified by affinity chromatography. The TBP–DNA complex is formed by mixing TBP with a 20–30 base pair DNA duplex containing the TATA box, and the complex is purified by gel filtration before crystallization or cryo-EM grid preparation.

Common Pitfalls and Misconceptions

Students frequently encounter several misconceptions when studying the TATA box. Being aware of these can prevent errors in understanding and in exam answers.

TATA-less promoters are common

The most pervasive misconception is that all eukaryotic promoters contain a TATA box. In reality, only a minority of promoters contain a canonical TATA box. In humans, approximately 80–90% of promoters are TATA-less. These promoters rely on other core promoter elements, such as the Inr and DPE, and on GC-rich sequences that bind the transcription factor Sp1. The TATA box is important, but it is not universal.

This misconception often arises because the TATA box is the most heavily studied core promoter element, and many textbook examples use TATA-containing promoters. When answering exam questions, it is essential to specify that the TATA box is found in a subset of promoters and that its absence does not preclude transcription.

TATA box is not the only determinant

A related misconception is that the TATA box alone is sufficient to drive transcription. In fact, the TATA box is necessary but not sufficient for transcription from a TATA-containing promoter. The core promoter also requires an Inr element or other downstream elements for accurate initiation. Moreover, the rate of transcription is determined by the combined action of the core promoter, proximal promoter elements, enhancers, and chromatin state.

In reporter assays, a TATA box alone typically produces very low levels of transcription. Adding an Inr element increases transcription, and adding upstream activator binding sites increases it further. The TATA box sets the baseline, but the final output is the product of multiple inputs.

Other common pitfalls include:

Confusing the TATA box with the Shine-Dalgarno sequence: The Shine-Dalgarno sequence is a prokaryotic ribosome-binding site, not a promoter element. The TATA box is eukaryotic and is involved in transcription, not translation.
Assuming the TATA box is bound by RNA polymerase: RNA polymerase II does not bind the TATA box directly. The TATA box is bound by TBP, which is part of TFIID. RNA polymerase II is recruited to the promoter through protein–protein interactions with TFIIB and TFIIF.
Forgetting the directionality: The TATA box is oriented relative to the transcription start site. Its position at −25 to −30 is critical; moving it changes the start site or abolishes transcription.
Overlooking the bend: TBP binding bends the DNA dramatically. This bend is not a side effect; it is functionally required for PIC assembly.

Summary and Practical Takeaways

The TATA box is a core promoter element that plays a central role in transcription initiation in eukaryotes. It is the binding site for TBP, which nucleates the assembly of the preinitiation complex. The TATA box is not universal, but where present, it is a major determinant of promoter strength and regulation.

Key points to remember

The TATA box is a conserved AT-rich sequence (consensus TATAAA) located approximately 25–30 base pairs upstream of the transcription start site.
It is bound by the TATA-binding protein (TBP), a subunit of TFIID, which bends the DNA by approximately 80–90 degrees.
TBP binding is the first step in PIC assembly, followed by recruitment of TFIIA, TFIIB, RNA polymerase II/TFIIF, and TFIIE/TFIIH.
Only 10–20% of human promoters contain a TATA box; TATA-less promoters use Inr and DPE elements instead.
TATA box mutations can reduce or increase transcription and are associated with human diseases such as beta-thalassemia and Gilbert's syndrome.
The TATA box is regulated by enhancers, silencers, and chromatin state; nucleosome positioning can occlude the TATA box and prevent TBP binding.
Key methods for studying the TATA box include reporter assays, EMSA, ChIP, and structural biology.

Exam tips

When writing about the TATA box in an exam, be precise about the following:

State the consensus sequence and location explicitly.
Name TBP as the binding protein, not RNA polymerase.
Describe the DNA bend and its functional significance.
Distinguish between TATA-containing and TATA-less promoters.
Give a concrete example of a disease caused by a TATA box mutation.
Mention that the TATA box is a core promoter element, not an enhancer or silencer.

Frequently Asked Questions

What is the TATA box in transcription?

The TATA box is a conserved DNA sequence found in the core promoter of many eukaryotic genes. It is located approximately 25–30 base pairs upstream of the transcription start site and serves as the binding site for the TATA-binding protein (TBP). The TATA box is one of several core promoter elements that direct the accurate initiation of transcription by RNA polymerase II.

Is the TATA box required for transcription?

No, the TATA box is not required for all transcription. Only about 10–20% of human promoters contain a TATA box. TATA-less promoters use other core promoter elements, such as the initiator (Inr) and downstream promoter element (DPE), to nucleate transcription initiation. However, in promoters that do contain a TATA box, it is typically required for efficient transcription.

What is the function of the TATA box in transcription?

The TATA box functions as the binding site for TBP, which is the first step in the assembly of the preinitiation complex. TBP binding to the TATA box bends the DNA and creates a platform for the recruitment of TFIIB, RNA polymerase II, and the remaining general transcription factors. The TATA box therefore determines where transcription begins and contributes to the efficiency of initiation.

Where is the TATA box located?

The TATA box is located in the core promoter, approximately 25–30 base pairs upstream of the transcription start site (+1). In yeast, it is often found at a greater distance, approximately 40–120 base pairs upstream. The precise spacing between the TATA box and the start site is important for accurate transcription initiation.

How does the TATA box affect transcription levels?

The TATA box affects transcription levels by determining the affinity of TBP binding. A strong TATA box (e.g., TATAAA) binds TBP with high affinity and supports high levels of transcription. Mutations that deviate from the consensus reduce TBP binding affinity and lower transcription levels. The TATA box also influences the responsiveness of a promoter to transcriptional activators.

What is the consensus sequence of the TATA box?

The canonical consensus sequence is 5′-TATAAA-3′. A more general consensus is 5′-TATAWAWR-3′, where W is adenine or thymine and R is adenine or guanine. The sequence is AT-rich, which is important for the minor-groove binding and DNA bending by TBP.

Does the TATA box bind RNA polymerase directly?

No. The TATA box is bound by the TATA-binding protein (TBP), which is a subunit of the TFIID complex. RNA polymerase II does not contact the TATA box directly. Instead, RNA polymerase II is recruited to the promoter through protein–protein interactions with TFIIB and TFIIF, which are themselves recruited to the TBP–TATA complex.

Key Takeaways

The TATA box is a conserved AT-rich core promoter element located at −25 to −30 relative to the transcription start site.
TBP binds the TATA box through the minor groove and induces an ~80–90° bend in the DNA, nucleating PIC assembly.
The TATA box is present in only 10–20% of human promoters; TATA-less promoters rely on Inr, DPE, and GC-rich elements.
TATA box mutations alter TBP binding affinity and transcription output, causing diseases such as beta-thalassemia and Gilbert's syndrome.
TATA box function is regulated by enhancers, silencers, and chromatin remodeling complexes that control DNA accessibility.
The TATA box is studied using reporter assays, EMSA, ChIP, and structural methods including X-ray crystallography and cryo-EM.
RNA polymerase II does not bind the TATA box directly; TBP mediates the interaction between the promoter and the transcriptional machinery.